AcouSort AB (publ) (STO:ACOU)
4.270
-0.170 (-3.83%)
Jun 11, 2026, 5:29 PM CET
AcouSort AB Revenue
AcouSort AB had revenue of 2.25M SEK in the quarter ending March 31, 2026, a decrease of -14.45%. This brings the company's revenue in the last twelve months to 10.05M, up 3.78% year-over-year. In the year 2025, AcouSort AB had annual revenue of 10.43M with 4.01% growth.
Revenue (ttm)
10.05M
Revenue Growth
+3.78%
P/S Ratio
8.99
Revenue / Employee
913.82K
Employees
11
Market Cap
90.37M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 10.43M | 402.00K | 4.01% |
| Dec 31, 2024 | 10.03M | -521.00K | -4.94% |
| Dec 31, 2023 | 10.55M | 1.97M | 22.90% |
| Dec 31, 2022 | 8.59M | 2.63M | 44.07% |
| Dec 31, 2021 | 5.96M | -864.00K | -12.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| IRLAB Therapeutics AB | 92.46M |
| Alzinova AB | 25.66M |
| Scandinavian ChemoTech AB | 12.61M |
| Biovica International AB | 10.93M |
| NextCell Pharma AB | 9.24M |
| Spago Nanomedical AB | 4.38M |
| Simris Group AB (PUBL) | 2.65M |
| Pila Pharma AB | 1.13M |
AcouSort AB News
- 16 days ago - AcouSort AB Quarterly report: Q1 2026 - Filings
- 3 months ago - AcouSort AB Quarterly report: Q4 2025 - Filings
- 3 months ago - AcouSort AB Annual report: Q4 2025 - Filings
- 7 months ago - AcouSort AB Quarterly report: Q3 2025 - Filings
- 10 months ago - AcouSort AB Quarterly report: Q2 2025 - Filings